RadNet Share Holder Equity 2010-2024 | RDNT

RadNet share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
RadNet Annual Share Holder Equity
(Millions of US $)
2023 $813
2022 $491
2021 $346
2020 $258
2019 $233
2018 $200
2017 $70
2016 $52
2015 $36
2014 $8
2013 $2
2012 $-7
2011 $-70
2010 $-82
2009 $-75
RadNet Quarterly Share Holder Equity
(Millions of US $)
2023-12-31 $813
2023-09-30 $796
2023-06-30 $761
2023-03-31 $493
2022-12-31 $491
2022-09-30 $458
2022-06-30 $451
2022-03-31 $421
2021-12-31 $346
2021-09-30 $339
2021-06-30 $299
2021-03-31 $281
2020-12-31 $258
2020-09-30 $246
2020-06-30 $233
2020-03-31 $207
2019-12-31 $233
2019-09-30 $215
2019-06-30 $212
2019-03-31 $214
2018-12-31 $200
2018-09-30 $121
2018-06-30 $125
2018-03-31 $116
2017-12-31 $70
2017-09-30 $74
2017-06-30 $64
2017-03-31 $53
2016-12-31 $52
2016-09-30 $40
2016-06-30 $37
2016-03-31 $38
2015-12-31 $36
2015-09-30 $26
2015-06-30 $12
2015-03-31 $7
2014-12-31 $8
2014-09-30 $3
2014-06-30 $-3
2014-03-31 $-9
2013-12-31 $2
2013-09-30 $0
2013-06-30 $5
2013-03-31 $2
2012-12-31 $-7
2012-09-30 $-59
2012-06-30 $-65
2012-03-31 $-69
2011-12-31 $-70
2011-09-30 $-76
2011-06-30 $-77
2011-03-31 $-82
2010-12-31 $-82
2010-09-30 $-88
2010-06-30 $-88
2010-03-31 $-79
2009-12-31 $-75
2009-09-30 $-78
2009-06-30 $-77
2009-03-31 $-84
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.083B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.429B 10.54
Quest Diagnostics (DGX) United States $15.377B 15.89
DaVita (DVA) United States $12.061B 14.98
Encompass Health (EHC) United States $8.712B 22.30
Chemed (CHE) United States $8.709B 26.99
Elanco Animal Health (ELAN) United States $8.401B 21.79
Option Care Health (OPCH) United States $5.235B 19.82
Amedisys (AMED) United States $3.121B 22.11
LifeStance Health (LFST) United States $2.622B 0.00
Astrana Health (ASTH) United States $2.179B 29.46
Addus HomeCare (ADUS) United States $1.789B 25.59
U.S Physical Therapy (USPH) United States $1.603B 42.90
Pennant (PNTG) United States $0.680B 35.94
Aveanna Healthcare Holdings (AVAH) United States $0.481B 0.00
Atai Life Sciences (ATAI) Germany $0.316B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.027B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00